Cargando…
Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options
Nonalcoholic fatty liver disease (NAFLD) is an emerging worldwide problem and its association with other metabolic pathologies has been one of the main research topics in the last decade. The aim of this review article is to provide an up-to-date correlation between hypothyroidism and NAFLD. We foll...
Autores principales: | Tanase, Daniela Maria, Gosav, Evelina Maria, Neculae, Ecaterina, Costea, Claudia Florida, Ciocoiu, Manuela, Hurjui, Loredana Liliana, Tarniceriu, Claudia Cristina, Floria, Mariana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460638/ https://www.ncbi.nlm.nih.gov/pubmed/32824723 http://dx.doi.org/10.3390/ijms21165927 |
Ejemplares similares
-
Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM)
por: Tanase, Daniela Maria, et al.
Publicado: (2020) -
Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives
por: Tanase, Daniela Maria, et al.
Publicado: (2022) -
Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
por: Tanase, Daniela Maria, et al.
Publicado: (2021) -
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
por: Tanase, Daniela Maria, et al.
Publicado: (2020) -
Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?
por: Tanase, Daniela Maria, et al.
Publicado: (2019)